-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Downgrades NeuroPace to Market Perform, Announces $7 Price Target

Benzinga·11/13/2026 12:39:04
Diffusion vocale
Leerink Partners analyst Mike Kratky downgrades NeuroPace (NASDAQ:NPCE) from Outperform to Market Perform and announces $7 price target.